On May 27 and 28, Surfing the NASH Tsunami covered the 5th Global NASH Congress, which discussed a wide range of topics related to Fatty Liver disease and Portable Liver Scans. In this conversation, Louise Campbell, who attended the conference on NASH Tsunami, discusses presentations she found of particular interest. Jörn Schattenberg and Roger Green, who did not attend, ask questions about the presentations and raise issues that come to mind as they listen.
Two major themes emerge from this conversation. The first, triggered by a presentation from e-Scopics, involved the value and use of in-office VCTE and ultrasound devices.
Louise discussed what she considered the clearest benefit of the e-Scopics machine (“I could see my liver”) and its major challenge, begin compared to FibroScan instead of biopsy (which makes the device, as Louise describes it, “a surrogate of a surrogate.”)
Roger asks whether cost or reimbursement ever came up in the context of the meeting since the cost of placing this kind of equipment in offices is likely not to prove financially viable. This leads to acknowledgment that cost never comes up in this kind of meeting, followed by Louise’s description of the Tawazun model as one way to make scanning more affordable.
More about Portable Liver Scans
The second was a look at liver disease from a patient’s point of view. The specific issue was liver volume. From the scientist’s perspective, it might be an interesting point, but seemingly unrelated to metabolic disease and not necessarily related to hepatic complications either. As Jörn points out, liver volume is the likely source of upper right quadrant pain, which would make it an important quality-of-life issue for patients. This brings the group back to the importance of having people in the room who can advocate for patients and take the patient perspective.
This conversation is part of S3-E27 – 5th Global NASH Congress Wrap-Up: Highlights & Speaker Interviews